Because we observed that the abscopal effects of local RT increased upon the addition of the BRD4 inhibitor, we profiled the immune cells in spleens and the tumor-draining lymph nodes to determine the effects of the treatments on systemic immunity. Here, BRD4 is linked to neoplasm.